Einige Inhalte dieser Seite sind nur für Abonnenten sichtbar.       Anmelden     oder      Jetzt abonnieren!
Neutralitäts- und Ernährungs-Initiative werden beide klar abgelehnt! Roche: FDA lässt Gazyva gegen Nierenerkrankung INS zu! SCHWEIZER AKTIENMARKT: Gesuchte UBS! Swiss Re und LSE: KI und Lieferketten eröffnen neue Wege für systemischen Stress, da Risiken immer stärker verbunden sind! KOF-Consensus: BIP 2026 +1,7% (+0,9%), 27 +1,6% (+1,5%); Inflation 26 +0,6% (+0,7%), 27 +0,7% (+0,8%)!
Novartis plant, bis 2022 im Zuge weltweiter Anpassungen der Produktion und der internen Dienstleistungen Stellen in der Schweiz zu reduzieren » Report
ASMALLWORLD AG (SWX: ASWN) übernimmt Luxusreise-Community First Class & More » Report
Addex to Present at the Investora Zurich Conference on 27 September » Report
ADDEX THERAPEUTICS RECOGNISED IN FINAL SHORTLIST FOR DEAL OF THE YEAR AT LIFESTARS AWARDS LIFE SCIENCE AWARDS FOR PARTNERSHIP WITH INDIVIOR » Report
Lonza's Capital Markets Day 2018 Outlines Sustainable Growth Plans Through Focus and Investment » Report
Tamedia-Nachbefragung: Junge stimmten eher für die Fair-Food-Initiative » Report
Zurich Insurance Group: Businesses are urged to build resilience to climate change impact » Report
Credit Suisse Neu in Zeichnung: BRC Netflix, Amazon in USD | 10% p.a. Coupon | 55% Barriere | 1 Jahr Laufzeit » Report
Roche's investigational medicine entrectinib showed a durable response of more than two years in people with a specific type of lung cancer » Report
Roche's Tecentriq in combination with pemetrexed and platinum-based chemotherapy reduced the risk of disease worsening or death in a type of previously untreated advanced lung cancer » Report
Julius Bär Warrants - New Issues » Report
Julius Bär Warrants - Top Trading » Report
Nestlé named UN Global Compact LEAD company » Report
EDI- Wachstum der Gesundheitskosten: Mittlere Krankenkassenprämie steigt um 1.2 Prozent » EDI
Neue Strukturierte Produkte Julius Bär » Report
Tamedia investiert in Fintech-Startup Lykke » Report
Basler Kantonalbank Bookbuilding: Swisscom AG emittiert eine CHF-Obligation » Report
ABB wins major order to enable transmission of clean energy in central Asia » Report
ASMALLWORLD AG (SWX:ASWN): Hansainvest increases stake in ASMALLWORLD AG to over 10% » Report
ASMALLWORLD AG (SWX: ASWN): Hansainvest erhöht Anteil an der ASMALLWORLD AG auf über 10% » Report
Matthias Huenerwadel wird CEO der Zehnder Group » Report
Significant shareholders - Significant shareholdings in companies whose equity securities are listed on SIX Swiss Exchange. » SIX
Bedeutende Aktionäre - Bedeutende Beteiligungen an Gesellschaften, deren Beteiligungspapiere an SIX Swiss Exchange kotiert sind. » SIX
Roche announces global availability of blood-based genomic profiling test, FoundationOne Liquid » Report
HBM Healthcare Investments: Erfolgreicher Börsengang von Y-mAbs Therapeutics erhöht Inneren Wert je HBM-Aktie um CHF 4.82 (+2.7%) » Report
SGS Implements Renovo™ Program in Ghana » Report
BIS Quarterly Review: Divergences widen in markets » Report
BIS Quarterly Review: Regulating cryptocurrencies: assessing market reactions » B.I.S.
Swiss Re: Agostino Galvagni has decided to step down, Andreas Berger will succeed him as CEO Corporate Solutions and member of the Group Executive Committee » Report
Aus dem Zentrum Malley wird die Vaudoise Aréna » Report
Novartis to file for new Lucentis® (ranibizumab) indication in retinopathy of prematurity (ROP), a rare disease in premature infants that often leads to blindness » Report
New analysis of Novartis Phase III brolucizumab (RTH258) data reinforces superior reduction of retinal fluid, a key marker of disease activity in nAMD » Report
STOXX Changes Composition Of Blue-Chip Indices » Report
STOXX Changes Composition Of Benchmark Indices » Report
ein schönes Wochenende, have a great weekend!
Glencore : Glencore announces the final price of convertible bonds » Report
Roche: CHMP recommends EU approval for subcutaneous formulation of RoActemra for use in active systemic juvenile idiopathic arthritis (sJIA), a rare form of juvenile arthritis » Report
Julius Bär Warrants - New Issues » Report
Roche announces CHMP recommendation for EU approval of Venclyxto plus MabThera for people with previously treated chronic lymphocytic leukaemia » Report
Sandoz receives positive CHMP opinion for proposed biosimilar pegfilgrastim » Report